Webinar – Arrays in Cancer Research
Xin Lu, Ph.D.
Understanding Immunosuppressive Myeloid Cells and Immunotherapy Using Proteome Profiler Antibody Arrays
Jan 29, 2018
Although immune checkpoint blockade is an effective therapeutic intervention for a variety of cancers, it is less effective against metastatic castration-resistant prostate cancer (mCRPC). To address this challenge, Dr. Xin Lu and his colleagues tested the hypothesis that immune checkpoint blockade (ICB) paired with the inhibition of the phosphoinositide 3-kinase (PI 3-K) pathway is a superior therapeutic intervention to ICB alone. Watch this video to see how they used Proteome Profiler™ Antibody Arrays to evaluate signaling in the context of combination therapy.